V

Vineti

70 employees

Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
enterprise software
clinical phase
pharm software
allogeneic therapy
data analytics
SaaS
chain of indentity
cell and gene therapy supply chain
autologous therapy
Cloud Computing
Enterprise Software
commercial phase
Therapeutics
automate
track and trace
Software
automated logistics orchestration
chain of custody

Date founded

2016

Funding rounds raised

Total raised

$35M

from 24 investors over 24 rounds

V

Vineti raised $33M on October 13, 2020

Investors: Novartis Japan, Casdin Capital, LLC, Section 32, Lifeforce Capital, Canaan and Threshold Ventures

V

Vineti raised $35M on February 5, 2020

Investors: Novartis Japan, Threshold Ventures, Casdin Capital, LLC, Section 32, -, Lifeforce Capital, Gilead Sciences and dRx data

V

Vineti raised $34M on April 16, 2018

Investors: Section 32, Mayo Clinic Ventures, Canaan, Lifeforce Capital, Threshold Ventures and GE Ventures

V

Vineti raised $14M on June 20, 2017

Investors: Mayo Clinic Ventures, GE Ventures, Threshold Ventures and Lifeforce Capital

FAQ